Patients were required to provide written educated consent. Major exclusion requirements were receipt of a P2Y12 inhibitor or abciximab anytime in the 7 days before randomization and receipt of eptifibatide or tirofiban or fibrinolytic therapy in the 12 hours before randomization. Study Treatment Patients were randomly assigned, in a double-dummy, double-blind manner, to receive cangrelor or clopidogrel before PCI. Randomization was performed by using an interactive voice-response or Web-response system, with stratification regarding to site, baseline status , and meant loading dose of clopidogrel .The BronchoGen genomic test has been created to fill up this gap. When utilized alongside standard bronchoscopy techniques, BronchoGen is intended to provide additional critical diagnostic details much earlier in the diagnostic procedure. Allegro can be leading a new paradigm for lung tumor management by introducing the potential for early detection, and we believe that this process has great guarantee both and commercially clinically, said Andrey Zarur, Handling Partner at Kodiak Venture Companions.